You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ranibizumab

Showing 1 - 25 of 263
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Branch Retinal Vein Occlusion, Ranibizumab, Laser Photocoagulation Trial in Beijing (Ranibizumab combined macular laser,

Completed
  • Branch Retinal Vein Occlusion
  • +2 more
  • Ranibizumab combined macular laser
  • Ranibizumab
  • Beijing, Beijing, China
    Beijing Hospital
Dec 25, 2022

Non-Ischemic Central Retinal Vein Occlusion With Macular Edema Trial in Qina (intravitreal injection of Ranibizumab,

Recruiting
  • Non-Ischemic Central Retinal Vein Occlusion With Macular Edema
  • intravitreal injection of Ranibizumab
  • +3 more
  • Qinā, Qena, Egypt
    Ahmed Ali Ahmed Amer
Mar 15, 2022

Wet Age-related Macular Degeneration Trial (Ranibizumab, SCT510A)

Not yet recruiting
  • Wet Age-related Macular Degeneration
  • (no location specified)
Jul 28, 2022

Neovascular Age-Related Macular Degeneration Trial in Worldwide (Ranibizumab, Aflibercept, Port Delivery System with ranibizumab

Suspended
  • Neovascular Age-Related Macular Degeneration
  • Ranibizumab
  • +2 more
  • Capital Federal, Argentina
  • +9 more
Nov 8, 2022

Age Related Macular Degeneration Trial in Nedlands (HLX04-O, ranibizumab)

Recruiting
  • Age Related Macular Degeneration
  • Nedlands, Western Australia, Australia
    Lions Eye Institute
Feb 7, 2022

Von Hippel-Lindau Syndrome Trial run by the NEI (Ranibizumab, E10030)

Completed
Has Results
  • Von Hippel-Lindau Syndrome
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 21, 2021

Age Related Macular Degeneration Trial in London (Ranibizumab, Aflibercept)

Completed
  • Age Related Macular Degeneration
  • London, UK, United Kingdom
    King's College Hospital NHS Foundation Trust
Apr 29, 2021

Pathological Myopic Choroidal Neovascularization Trial in BeiJing (601, Ranibizumab)

Recruiting
  • Pathological Myopic Choroidal Neovascularization
  • BeiJing, China
    Peking Union Medical College Hospital
Jun 4, 2021

Diabetic Macular Edema Trial in Worldwide (RO7200220, Ranibizumab, Sham Procedure)

Recruiting
  • Diabetic Macular Edema
  • Arcadia, California
  • +29 more
Aug 18, 2022

Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

Not yet recruiting
  • Exudative Age Related Macular Degeneration
  • Ranibizumab
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Health Sciences
Nov 28, 2022

Anti-VEGF in Real-world

Recruiting
  • Neovascular Age-related Macular Edema
  • +5 more
  • Ranibizumab
  • +2 more
  • Beijing, Beijing, China
    Wen-Bin Wei
Feb 2, 2022

Diabetic Macular Edema, Cataract Trial in Walnut Creek (Bevacizumab, Ranibizumab, Aflibercept)

Recruiting
  • Diabetic Macular Edema
  • Cataract
  • Walnut Creek, California
    Bay Area Retina Associates
Mar 1, 2022

Central Retinal Vein Occlusion Trial in Stockholm (Aflibercept, Ranibizumab)

Completed
  • Central Retinal Vein Occlusion
  • Stockholm, Sweden
    St Eriks Eye Hospital
Dec 3, 2020

Diabetic Macular Edema Trial in Cleveland, Mayfield Heights (Ranibizumab)

Completed
Has Results
  • Diabetic Macular Edema
  • Ranibizumab
  • Cleveland, Ohio
  • +1 more
Oct 30, 2020

Diabetic Retinopathy, Retinal Neovascularisation Trial in London (Ranibizumab, Saline)

Completed
  • Diabetic Retinopathy
  • Retinal Neovascularisation
  • London, United Kingdom
    Moorfields Eye Hospital
Sep 7, 2020

Ophthalmopathy Trial in Asyut (Ranibizumab, triamcinolone acetate)

Unknown status
  • Ophthalmopathy
  • Ranibizumab
  • triamcinolone acetate
  • Asyut, Egypt
    Wael
Jul 2, 2020

Neovascular Age-related Macular Degeneration (nAMD) Trial in Worldwide (Ranibizumab, Port Delivery System with Ranibizumab)

Recruiting
  • Neovascular Age-related Macular Degeneration (nAMD)
  • Ranibizumab
  • Port Delivery System with Ranibizumab
  • Capital Federal, Argentina
  • +84 more
Aug 2, 2022

Cytokeratin 8 Level in Age-related Macular Degeneration

Completed
  • Age-related Macular Degeneration
  • Ranibizumab
  • Goyang, Korea, Republic of
  • +1 more
Dec 5, 2020

Retinopathy of Prematurity Trial in Worldwide (Ranibizumab)

Active, not recruiting
  • Retinopathy of Prematurity
  • Ranibizumab
  • Sacramento, California
  • +72 more
May 23, 2022

Diabetic Retinopathy Trial in London (Ranibizumab, Modified ETDRS laser)

Completed
  • Diabetic Retinopathy
  • Ranibizumab
  • Modified ETDRS laser
  • London, United Kingdom
    Moorfields Eye Hospital
Sep 7, 2020

Age-Related Maculopathy, Choroidal Neovascularization Trial in Tulsa (Ranibizumab, Verteporfin)

Completed
Has Results
  • Age-Related Maculopathy
  • Choroidal Neovascularization
  • Tulsa, Oklahoma
    Eagle Mountain Vision
Nov 4, 2020

Macular Degeneration Trial in United States (Ranibizumab)

Completed
Has Results
  • Macular Degeneration
  • Ranibizumab
  • Mesa, Arizona
  • +49 more
Apr 12, 2021

Automated Optical Coherence Tomography Image Enrichment With

Active, not recruiting
  • Neovascular Age-Related Macular Degeneration
  • Hamilton, Ontario, Canada
  • +16 more
Aug 8, 2022

Proliferative Diabetic Retinopathy, Diabetic Macular Edema Trial in Ningbo, Shanghai (drug, other, procedure)

Unknown status
  • Proliferative Diabetic Retinopathy
  • Diabetic Macular Edema
  • Ranibizumab
  • +2 more
  • Ningbo, Zhejiang, China
  • +2 more
Jul 7, 2020

Wet Macular Degeneration, Wet Age-related Macular Degeneration Trial in Virginia Beach (Ziv-Aflibercept 25 MG/ML [Zaltrap],

Completed
  • Wet Macular Degeneration
  • Wet Age-related Macular Degeneration
  • Ziv-Aflibercept 25 MG/ML [Zaltrap]
  • Ranibizumab
  • Virginia Beach, Virginia
    Wagner Macula & Retina Center
Oct 5, 2020